A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Colorectal Cancer Metastatic
- Status
- COMPLETED
- Phase
- PHASE3
A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Protocol of Irinotecan for Carcinoma of the Lung
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI
- Status
- COMPLETED
- Phase
- PHASE2
Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC
- Status
- WITHDRAWN
- Phase
- NA